ScholarWorks@Hanyang University: Kim, Gheun-Ho

Detailed Information

Kim, Gheun-Ho (김근호)

서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)

Research Area: 신장내과, 신장생리, Clinical nephrology, Renal physiology

Tel 02-2290-8318
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Kidney transplantation:9||Hypertension:8||Hyponatremia:8||aquaporin2:6||Hemodialysis:6||Calcium:5||Uric acid:5||Blood pressure:5||Guidelines:5||Proteinuria:5||Cardiovascular risk:4||Mortality:4||Sodium:4||Kidney:4||hyponatremia:4||Chronic kidney disease:4||Antihypertensive treatment:4||Phosphorus:4||Parathyroid hormone:4||Hemoglobin:3||Cyclophosphamide:3||Kidney failure:3||Water:3||Lifestyle:3||Proximal tubule:3||Fibrosis:3||Renal dialysis:3||water:3||Secondary hyperparathyroidism:3||Parathyroidectomy:3||Anemia:3||vasopressin2 receptor:2||tight junction:2||Dialysis:2||collecting duct:2||Cystatin C:2||Lymphoproliferative disorders:2||cyclophosphamide:2||Lupus nephritis:2||Rhematoid arthritis:2||Hyperuricemia:2||Community acquired acute pyelonephritis:2||Glomerular filtration rate:2||Lung neoplasms:2||PositronEmission Tomography:2||Hypouricemia:2||Azotemia:2||Albuminuria:2||sodium:2||Cardiovascular complications:2||Osteoporosis:2||Hydronephrosis:2||Ciprofloxacin:2||Cisplatin:2||inflammation:2||Diagnosis:2||Prevalence:2||Staphylococcus:2||Claudin:2||oxidative stress:2||Empirical therapy:2||Takayasu arteritis:2||Hematinics:2||Peritoneal dialysis:2||Disease progression:2||Quinolone resistance:2||Peritonitis:2||tolvaptan:2||NADPH oxidase:2||Tolvaptan:2||Dronedarone:1||Drug hypersensitivity:1||Drug interactions:1||Ecadherin:1||EHHADH gene:1||Edema:1||Elderly:1||Electrolytes:1||Empagliflozin:1||Enalapril:1||Endstage renal disease:1||Epidemiology:1||Erythropoiesis stimulating agent:1||Extended RRS:1||Fanconi syndrome:1||Fractures:1||GLUT2:1||Gene therapy:1||Gene transfer techniques:1||Glomerulonephritis:1||Glomerulus:1||Glycosuria:1||Gout:1||Graft survival:1||Guideline:1||HLAB*58:01 allele:1||Hemodiafiltration:1||Hemodialysis solution:1||Heparin:1||Hepatocyte growth factor:1||Hepcidin:1||Hepcidin as a Biomarker of Cardiorenal Syndrome:1||Hypercalcemia:1||Hypercalciuria:1||Hyperkalemia:1||Hyperlipidemia:1||Hyperparathyroidism:1||Hyperproteinemia:1||Hyperuricosuria:1||Hypokalemia:1||Hypoxia inducible transcription factor:1||Hypoxiainducible factor1:1||ICU:1||Idiopathic Fanconi syndrome:1||IgA nephropathy:1||Immunoglobulin A:1||Implementation:1||Inappropriate ADH Syndrome:1||Inflammasome:1||Inflammation:1||Initial Problems:1||Initial database:1||Intact parathyroid hormone:1||Intravenous immunoglobulin:1||Kidney concentrating ability:1||Kidney diseases:1||Kidney protection:1||Local adaptation:1||Masked hypertension:1||Measurement:1||Metabolic acidosis:1||NFkappa B:1||NaK2Cl cotransporter:1||NaK2Cl cotransporter type 2:1||National Health and Nutrition Examination Survey:1||Natriuresis:1||Nontuberculous mycobacterium:1||ORCHESTRA:1||Occludin:1||Organ damage:1||Organdamage:1||Organic anion transporter:1||Osmotic diuresis:1||Outcome:1||Paget's disease:1||Paracellular permeability:1||Pathology:1||Patient survival:1||Patiromer:1||Phosphaturia:1||Physiology:1||Plasmapheresis:1||Polycystic kidney disease:1||Population:1||Postinfectious glomerulonephritis:1||Potassium:1||Potentiometry:1||Pressure natriuresis:1||Prevention:1||Problem oriented medical record:1||Prostaglandins:1||Proteintocreatinine ratio:1||Pseudohyponatremia:1||Pulmonary arterial hypertension:1||Puromycin:1||Puromycin aminonucleoside:1||Pyelonephritis:1||Rapid Response System:1||Rat:1||Renal biopsy:1||Renal insufficiency:1||Renal osteodystrophy:1||Renal replacement therapy:1||Renal tubular acidosis:1||Right heart failure:1||Rupture:1||Saltsensitive hypertension:1||Secondary Hyperparathyroidism:1||Secondary hyperparathyroidism.:1||Skin neoplasms:1||Smad proteins:1||Sodium bicarbonate:1||Sodium chloride:1||Sodium chloride symporter:1||Sodium polystyrene sulfonate:1||Sodium zirconium cyclosilicate:1||Sodiumselective electrode:1||Sudden:1||Syndrome of inappropriate antidiuresis:1||Systemic lupus erythematosus:1||Thiazides:1||Thick ascending limb:1||Tight junction proteins:1||Transforming growth factorbeta:1||Transplantation:1||Treatment:1||Tubular transport:1||Tubuloglomerular feedback:1||Tubulointerstitial injury:1||Urateanion exchanger:1||Uric acid transport:1||Urinary concentration:1||Urine protein electrophoresis:1||Vasopressins:1||Voriconazole:1||WNK4 protein:1||Water diuresis:1||Water intoxication:1||White coat hypertension:1||adherence:1||amiloride:1||antidepressant:1||autosomal dominant tubulointerstitial kidney disease:1||blood temperature monitoring:1||cAMP:1||calcium:1||carbamazepine:1||chronic kidney disease:1||cisplatin:1||claudin15:1||claudin16:1||claudin19:1||complication:1||cyclooxygenase2:1||diabetes mellitus:1||diabetic retinopathy:1||dipeptidyl peptidase4 inhibitor:1||distal acidification:1||diuretics:1||epithelialmesenchymal transition:1||extramammary:1||fibrosis:1||glucagonlike peptide1 receptor agonist:1||haloperidol:1||hypertension:1||hyperuricemia:1||hyponatraemia:1||hypouricemia:1||immunoblotting:1||intercalated cells:1||kidney:1||kidney cortex necrosis:1||lipotoxicity:1||lithium:1||lowsodium diet:1||lupus:1||lupus erythematosus:1||lymphoma:1||magnesium:1||mesothelial cell:1||metformin:1||microalbuminuria:1||nephrogenic antidiuresis:1||nephrogenic syndrome of inappropriate antidiuresis:1||nephrotic syndrome:1||obesity:1||occludin:1||oedema:1||pendrin:1||peritoneal dialysis:1||peritoneal transport:1||polyclonal antiH+ATPase B1 subunit antibody:1||preference:1||pressurenatriuresis:1||reninangiotensin system:1||risk:1||saltsensitivity:1||sertraline:1||sitagliptin:1||sodiumglucose transporter2 inhibitor:1||syndrome of inappropriate ADH secretion:1||systemic:1||thiazides:1||thick ascending limb:1||transforming growth factor:1||urinary albumin creatinine ratio:1||vascular access:1||vascular resistance:1||vasopressin:1||vasopressin V2 receptor:1||vasopressin receptor type 2:1||vasopressins:1||고혈압:1||급성신부전:1||단백뇨:1||당뇨병:1||류마티스관절염:1||만성콩팥병:1||바소프레신 제2수용체:1||부갑상선호르몬:1||부적절항이뇨증후군:1||부종:1||사구체신염:1||사구체여과율:1||세관 사구체되먹임:1||수분:1||수액요법:1||시스타틴 씨:1||시스플라틴:1||식염수:1||신독성:1||신성골형성장애:1||신장보호:1||신장이식:1||심부전:1||아세틸시스테인:1||알부민뇨:1||이뇨제:1||저나트륨혈증:1||조영제:1||중탄산염:1||질소혈증:1||체액결핍:1||칼슘:1||칼시트리올:1||크레아티닌:1||폐암:1||AST120:1||혈액투석액:1||Acetylcysteine:1||Activin:1||Acute kidney failure:1||Acute kidney injury:1||Albumin:1||Albumintocreatinine ratio:1||Albumintoprotein ratio:1||Alkaline phosphatase:1||Allograft survival:1||Allopurinol:1||Amyotrophic lateral sclerosis:1||Antiglomerular basement membrane disease:1||Anticoagulation:1||Antiphospholipid syndrome:1||Aquaporin 1:1||Aquaporin2:1||Assessment:1||AtRisk Patient:1||Awareness:1||Beta 2microglobulin:1||Biochemical marker:1||Blood flow:1||Blood pressure measurement:1||Bone mineral densitometry:1||COVID19:1||Calcitriol:1||Calcium polystyrene sulfonate:1||Calcium transport:1||Cardiac:1||Cardiovascular mortality:1||Cardiovascular outcome:1||Chronic:1||Chronic Renal Insufficiency:1||Chronic kidney diseasemineral and bone disorder:1||Chronic kidney diseases:1||Cicletanine:1||Citric acid:1||Claudin1:1||Claudin4:1||Claudinopathy:1||Cohort:1||Collecting duct:1||Complication:1||Complications:1||Contrast media:1||Control:1||Corticosteroids:1||Creatinine:1||Criticallyill:1||Cyclosporin:1||Cyclosporine:1||Cyclosporine nephrotoxicity:1||Cyst:1||DFU:1||DW7202:1||Dahl saltsensitive rats:1||Death:1||Desmopressin:1||Diabetes:1||Diabetes mellitus:1||Diagnostic and therapeutic approaches:1||Diet, sodiumrestricted:1||Dietary NaCl:1||Dietary intake:1||Dipeptidyl peptidase4:1||Diuresis:1||Diuretics:1||Doxorubicin:1||Doxorubucin:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE